Real-life effectiveness of omalizumab in difficult-to-treat versus severe asthma: a national cohort study in Belgium
Background Guidelines recommend omalizumab in patients with uncontrolled severe allergic asthma. We investigated real-life use of omalizumab, the proportion of patients fulfilling eligibility criteria, its costs and its effectiveness. Method In a cohort of asthma patients initiating treatment with o...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Respiratory Society
2019-11-01
|
| Series: | ERJ Open Research |
| Online Access: | http://openres.ersjournals.com/content/5/4/00253-2018.full |